Jenny Homewood

Multimodal neurophysiological evaluation of primary progressive multiple sclerosis - An increasingly valid biomarker, with limits.

P. Walsh, N. Kane, K. Inglis, 2015, Multiple sclerosis and related disorders.

Results of a randomized, double blind, placebo controlled, crossover trial of melatonin for treatment of Nocturia in adults with multiple sclerosis (MeNiMS)

K. Inglis, D. Cottrell, P. White, 2018, BMC Neurology.